Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 1/20 | 0.69 |
| ▸ | GPR35 | Q9HC97 | 9/20 | 0.61 |
| ▸ | CRHBP | P24387 | 1/20 | 0.53 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | TTR | P02766 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4167284 | 0.89 | ERN1 (0.62) | ERN1GPR35CA12CA1CA2 | |
| SCHEMBL7737429 | 0.89 | ERN1 (0.62) | ERN1GPR35CRHBPCRHR2CA12 | |
| SCHEMBL29674743 | 0.86 | ERN1 (0.59) | ERN1GPR35CA12CA1CA2 | |
| SCHEMBL4293562 | 0.86 | GPR35 (0.65) | ERN1GPR35CRHBPCRHR2CA12 | |
| SCHEMBL1736226 | 0.86 | GPR35 (0.65) | ERN1GPR35CRHBPCRHR2CA12 | |
| SCHEMBL752254 | 0.86 | ERN1 (0.59) | ERN1GPR35CA12CA1CA2 | |
| SCHEMBL28543052 | 0.86 | GPR35 (0.65) | ERN1GPR35CA12CA1CA2 | |
| SCHEMBL19327235 | 0.85 | ERN1 (0.57) | ERN1GPR35ALDH1A1MEN1MAPT | |
| SCHEMBL70055 | 0.84 | ERN1 (0.57) | ERN1GPR35CRHBPCRHR2ALDH1A1 | |
| SCHEMBL928630 | 0.82 | ERN1 (1.00) | ERN1ALDH1A1MEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8846978-B2 | Electronic devices comprising novel phosphonic acid surface modifiers | IMPERIAL INNOVATIONS LTD. (GB) | 2014-09-30 | — | — | US | disclosed |
| US-20120114974-A1 | ELECTRONIC DEVICES COMPRISING NOVEL PHOSPHONIC ACID SURFACE MODIFIERS | NATIONAL SCIENCE FOUNDATION | 2012-05-10 | — | — | US | disclosed |
| US-20110114935-A1 | Stable electrodes with modified work functions and methods for organic electronic devices | GEORGIA TECH RESEARCH CORPORATION (US) | 2011-05-19 | — | — | US | disclosed |
| EP-0352489-B1 | USE OF 2,6-DINITROPHENOL DERIVATIVES IN HAIR DYEING COMPOSITIONS | Wella Aktiengesellschaft (DE) | 1992-06-17 | — | — | EP | disclosed |
| US-4975093-A | Hair dyeing compositions containing 2,6-dinitro-phenol-derivatives | WELLA AKTIENGESELLSCHAFT (DE) | 1990-12-04 | — | — | US | disclosed |
| EP-0352489-A2 | Use of 2,6-dinitrophenol derivatives in hair dyeing compositions | Wella Aktiengesellschaft (DE) | 1990-01-31 | — | — | EP | disclosed |
| EP-0000162-B1 | Method for preparing aralkyl and alkyl phenol ethers | BASF Aktiengesellschaft (DE) | 1980-08-20 | — | — | EP | disclosed |
| US-4192949-A | FROM CORRESPONDING PHENOLS BY ETHERIFICATION WITH DIALKYL CARBONATE IN TERTIARY AMINE OR PHOSPHINE | BASF AKTIENGESELLSCHAFT (DE) | 1980-03-11 | — | — | US | disclosed |
| EP-0000162-A1 | Method for preparing aralkyl and alkyl phenol ethers | BASF Aktiengesellschaft (DE) | 1979-01-10 | — | — | EP | disclosed |
| US-3984405-A | PYRIDO(3,2-B)(1,4)OXAZIN-3(4H)-ONES | E. R. SQUIBB & SONS, INC. (US) | 1976-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110114935-A1 | Stable electrodes with modified work functions and methods for organic electronic devices | EPCAM, EMD, L1CAM | ERN1 526/4885GPR35 4353/4885CRHBP 1692/4885 |
| US-20120114974-A1 | ELECTRONIC DEVICES COMPRISING NOVEL PHOSPHONIC ACID SURFACE MODIFIERS | EFNA1, PHOSPHO1, EPHA6 | ERN1 334/4885GPR35 3216/4885CRHBP 4793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.